Loading organizations...
§ Private Profile · Oslo, Oslo, Norway
Nasal drug delivery technologies for efficient medication administration.
OptiNose has raised $115.5M across 3 funding rounds.
OptiNose has raised $115.5M in total across 3 funding rounds.
OptiNose has raised $115.5M in total across 3 funding rounds.
OptiNose's investors include Fidelity Management & Research Company, Avista Capital Partners, Entrepreneurs Fund.
OptiNose has raised $115.5M across 3 funding rounds. Most recently, it raised $37.0M Series D in May 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 9, 2017 | $37M Series D | Fidelity Management & Research Company | Avista Capital Partners, Entrepreneurs Fund | Announced |
| Oct 6, 2015 | $30M Venture Round | — | — | Announced |
| Jun 8, 2010 | $48.5M Venture Round | Avista Capital Partners | — | Announced |